UJohimbe ungumuthi ovuthiwe okhula entshonalanga ye-Afrika eNigeria, eCameroon, eCongo naseGabon. Amagxolo omuthi aqukethe ama-acteri esebenzayo okuthiwa i-alkaloids. I-alkaloid eyinhloko ibizwa ngokuthi i-yohimbine.
I-Yohimbine yisidakamizwa semithi e-United States yokwelashwa kokungasebenzi kahle kwe-erectile. Ukuthandwa kwalo kuye kwadlula kusukela kokusungulwa kwe- Viagra .
Izitshalo zeJohimbe bark nazo zithengiswa ezitolo zokudla ezempilo nase-intanethi. E-Germany, ayivunyelwe ukusetshenziswa. I-Yohimbe ingabangela ukwanda okuyingozi emzimbeni wegazi, kanye nokukhathazeka neminye imiphumela emibi.
Igama lesiLatin lomuthi uJohhimbe u-Pausinystalia yohimbe .
Kungani Abantu Basebenzisa Yohimbe?
Ngokwesiko, uJohimbe wasebenzisa e-Afrika ngenxa yomkhuhlane, ukukhwehlela, uchoko, kanye ne-aphrodisiac. Kuze kube manje, ubufakazi besayensi obusekela izinzuzo zikaJohimbe ezingenakwenzeka.
1) Ukungasebenzi kwe-Erectile
Izitshalo zeJohimbe bark zithuthukiswa kabanzi kwi-inthanethi nakwezitolo zokudla ezempilo njenge- aphrodisiac yemvelo ukwandisa i-libido nokuphatha ukungasebenzi kahle kwe-erectile. Kodwa-ke, abukho ubufakazi bokukhombisa ukuthi izithako ze-herbal ziyasebenza. Ucwaningo oluningi lwezokwelapha luye lwabuka i-yohimbine yezidakamizwa hhayi umkhiqizo wezolimo uJohimbe.
Izifundo ekusebenzeni kwe-yohimbine ziye zaba nokuthola okuphikisanayo. Ukuze kusetshenziswe i-erectile i-dysfunction (i-erectile dysfunction ngenxa yenkinga yangempela), isifundo esisodwa esingalawuleki sathola ukuthi i-yohimbine yayizuzisa amadoda ane-organic erectile disys function.
Esinye isifundo sathola ukuthi asiphumelelanga kakhulu kune-placebo.
Ucwaningo lwaseJalimane luhlolisise ukuthi ngabe i-30 mg / day yohimbine yamaviki angu-4 kungasiza abesilisa nge-erectile ukungasebenzi ngenxa yenkinga yangempela. I-Yohimbine itholakala ukuthi iyasebenza kakhulu kune-placebo (71% vs 45%).
2) Ukulahlekelwa Isisindo
I-Yohimbine itholakale ekucwaningeni kokuqala ukwenzela ukwandisa i-lipolysis ngokukhulisa ukukhululwa kwe-norepinephrine etholakalayo kuma-fat cells futhi kuvimbela ukusebenza kwe-alpha-2 receptor.
Kodwa-ke, isifundo esilawulwayo sathola ukuthi i-43 mg / day Yohimbe ayinayo ithonya emzimbeni wesisindo, inkomba yomzimba womzimba, amafutha omzimba, ukusabalalisa amafutha, namazinga e-cholesterol.
3) Ukucindezeleka
U-Yohimbe uphakanyiswe njengendlela yokwelapha ye- herbal yokucindezeleka ngoba ivimbela i-enzyme ebizwa ngokuthi i-monoamine oxidase. Noma kunjalo, lokhu kutholakala kuphela kumazinga aphezulu (ngaphezu kuka-50 mg / ngosuku), okungenzeka kungaphephile.
Amapulangwe
Naphezu kwezinzuzo ezibhekiswe kuJohimbe, akufanele kuthathwe kunikezwe izingozi ezinkulu zezempilo. Kubalulekile ukuthi uxoxe nodokotela wakho uma usacabanga ukusebenzisa i-Yohimbe.
EJalimane, uJohimbe useKhomishana E (i-e-country's herbal regulatory agency) uhlu lwezamakhemikhali ezingavunyelwe ngenxa yokukhathazeka ngokuphepha nokusebenza kwamalimi. E-United States, i-FDA iye yaba nemibiko eminingi yokuhlukunyezwa nokuhluleka kwezinso ngemuva kokusebenzisa uJohimbe.
I-Yohimbe ayinconywa ngoba ine-index yokwelapha encane kakhulu. Kukhona uhla oluncane olulinganiselwe-ngaphansi kwalo, isitshalo asisebenzi futhi ngaphezu kwalo isitshalo siyingozi.
Imiphumela emibi yemithi ejwayelekile ingabandakanya ukuzondeka, ukuhlukunyezwa, ukulala, ukukhathazeka, ukushaya kwenhliziyo okusheshayo nokunyuka kwengcindezi yegazi.
Uma nje u-40 mg ngosuku ungabangela imiphumela emibi kakhulu, njengokushintsha kwengozi yengcindezi yegazi, ukucubungula, ukukhubazeka, izinso zesibindi, izinso nezinhliziyo, futhi kungase kube nokubulala.
Ngenxa yokuthi i-yohimbine ivimbela i-enzyme i-monoamine oxidase, abantu abathatha u-Yohimbe kumele bagweme ukudla konke okune-tyramine (isib. Isibindi, ushizi, iwayini elibomvu) nemikhiqizo engaphezu kwezinto eziqukethe isithako phenylpropanolamine, njengama-decongestants asemanzini.
Abantu abanesifo sezinso noma isibindi, izilonda zesisu, isifo senhliziyo, ukucindezela kwegazi eliphezulu, ukucindezeleka kwegazi okuphansi, ukucindezeleka kokucindezeleka ngemva kokucindezeleka, nokuphazamiseka kwesifo akufanele kuthathe uJohimbe.
I-Yohimbe akufanele ithathwe ngabesifazane abakhulelwe noma abahlengikazi, izingane noma abantu asebekhulile.
I-Yohimbe akufanele ihlanganiswe nezidakamizwa zokucindezeleka ngaphandle uma kungaphansi kokuqondiswa udokotela.
Ama-supplement ye-Yohimbe awazange ahlolwe ukuphepha futhi agcine engqondweni ukuthi ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo ayisungulwa. Ungathola amathiphu ekusebenziseni izithako lapha, kodwa uma ucabangela ukusetshenziswa kukaJohimbe, kubalulekile ukuthi ukhulume nodokotela wakho kuqala.
> Imithombo:
> Guay AT et al. "Yohimbine Ukwelashwa Kwe-Organic Erectile Dysfunction in Trial-Escalation Trial". I-International Journal of Impotence Research. 14.1 (2002): 25-31.
> Mann K et al. "Imiphumela ye-Yohimbine ekuhlangenwe nakho kobulili nobusuku obunama-nocturnal Penile Tumescence kanye nobuqotho e-Erectile Dysfunction". I-Archives yokuziphatha ngokocansi. 25.1 (1996): 1-16.
> Morales A et al. "Ingabe i-Yohimbine iphumelela ekwelapheni kwe-Organic Impotence? Imiphumela ye-Trial Controled". Journal of Urology. 137.6 (1987): 1168-72.
> Sax L. "Yohimbine Ayithinti Ukusabalalisa Amafutha Kwabesilisa". I-International Journal of Obesity. 15.9 (1991): 561-5.
> Vogt HJ et al. "Ukuphulukiswa kabili, ukuPhepha okuPhezulu okuPhezulu nokuPhepha okuPhezulu nge-Yohimbine Hydrochloride ekuPhilweni kweDisfunction engeyona engavamile ye-Erectile". I-International Journal of Impotence Research. 9.3 (1997): 155-61.